FNDC5 and Sepsis: We found that patients who presented higher irisin levels during the first week of sepsis had better outcomes at 28 days after sepsis onset, which supports a beneficial and protective role of irisin against sepsis-induced organ dysfunction, in line with in vitro and in vivo experimental data.